BTIG analyst Ryan Zimmerman downgraded Histogenics Corp. (NASDAQ: HSGX) from Buy to Neutral.The analyst comments "The totality of the data ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE